A review on ZnO nanostructured materials: energy, environmental and biological applications
J Theerthagiri, S Salla, RA Senthil… - …, 2019 - iopscience.iop.org
Zinc oxide (ZnO) is an adaptable material that has distinctive properties, such as high-
sensitivity, large specific area, non-toxicity, good compatibility and a high isoelectric point …
sensitivity, large specific area, non-toxicity, good compatibility and a high isoelectric point …
[HTML][HTML] Peptide-drug conjugates and their targets in advanced cancer therapies
P Hoppenz, S Els-Heindl, AG Beck-Sickinger - Frontiers in chemistry, 2020 - frontiersin.org
Cancer became recently the leading cause of death in industrialized countries. Even though
standard treatments achieve significant effects in growth inhibition and tumor elimination …
standard treatments achieve significant effects in growth inhibition and tumor elimination …
Biomedical applications of zinc oxide nanomaterials
Nanotechnology has witnessed tremendous advancement over the last several decades.
Zinc oxide (ZnO), which can exhibit a wide variety of nanostructures, possesses unique …
Zinc oxide (ZnO), which can exhibit a wide variety of nanostructures, possesses unique …
A combined “eat me/don't eat me” strategy based on extracellular vesicles for anticancer nanomedicine
Z Belhadj, B He, H Deng, S Song, H Zhang… - Journal of …, 2020 - Taylor & Francis
ABSTRACT A long-term and huge challenge in nanomedicine is the substantial uptake and
rapid clearance mediated by the mononuclear phagocyte system (MPS), which enormously …
rapid clearance mediated by the mononuclear phagocyte system (MPS), which enormously …
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy
New blood vessel formation (angiogenesis) is fundamental to tumor growth, invasion, and
metastatic dissemination. The vascular endothelial growth factor (VEGF) signaling pathway …
metastatic dissemination. The vascular endothelial growth factor (VEGF) signaling pathway …
[HTML][HTML] On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …
Modification of kidney barrier function by the urokinase receptor
C Wei, CC Möller, MM Altintas, J Li, K Schwarz… - Nature medicine, 2008 - nature.com
Podocyte dysfunction, represented by foot process effacement and proteinuria, is often the
starting point for progressive kidney disease. Therapies aimed at the cellular level of the …
starting point for progressive kidney disease. Therapies aimed at the cellular level of the …
Nanoplatforms for targeted molecular imaging in living subjects
Molecular or personalized medicine is the future of patient management and molecular
imaging plays a key role towards this goal. Recently, nanoplatform‐based molecular …
imaging plays a key role towards this goal. Recently, nanoplatform‐based molecular …
Multimodality molecular imaging of tumor angiogenesis
Molecular imaging is a key component of 21st-century cancer management. The vascular
endothelial growth factor (VEGF)/VEGF receptor signaling pathway and integrin α v β 3, a …
endothelial growth factor (VEGF)/VEGF receptor signaling pathway and integrin α v β 3, a …
Integrin αvβ3‐targeted cancer therapy
Z Liu, F Wang, X Chen - Drug development research, 2008 - Wiley Online Library
Anti‐angiogenesis is a promising strategy for the treatment of cancer. Integrins, consisting of
two noncovalently bound transmembrane α and β subunits, are an important molecular …
two noncovalently bound transmembrane α and β subunits, are an important molecular …